Prospective analysis of the impact of HLA-DR and -DQ on joint destruction in recent-onset rheumatoid arthritis

Rheumatology

Volumn 42, Issue 4, 2003, Pages 553-562

  Wagner, U ^c   Kaltenhauser S ^c   Pierer, M ^c   Seidel, W ^c   Troltzsch M ^c   Hantzschel H ^c   Kalden, J R ^a   Wassmuth, R ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Epidemiology; Human leucocyte antigens (HLA); Immunogenetics; Joint destruction; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; CORTICOSTEROID; EPITOPE; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADULT; ALLELE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE DOSAGE; GENE LOCUS; GENOTYPE; HLA SYSTEM; HOMOZYGOSITY; HUMAN; JOINT DESTRUCTION; JOINT RADIOGRAPHY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; SCORING SYSTEM;

ADULT; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RHEUMATOID FACTOR;

EID: 0345700819     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg190     Document Type: Article

References (37)

1. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987;30:1205-13.
2. Cairns JS, Curtsinger JM, Dahl CA, Freeman S, Alter BJ, Bach FH. Sequence polymorphism of HLA DR beta 1 alleles relating to T-cell-recognized determinants. Nature 1985;317:166-8.
3. Weyand CM, Hicok KC, Conn DL, Goronzy JJ. The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med 1992;117:801-6.
4. Gough A, Faint J, Salmon M et al. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum 1994;37:1166-70.
5. Toda Y, Minamikawa Y, Akagi S et al. Rheumatoid-susceptible alleles of HLA-DRB1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA. Ann Rheum Dis 1994;53:587-92.
6. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992;35:749-55.
7. Salvarani C, Macchioni P, Mantovani W, Portioli I. Polymyalgia rheumatica and seronegative rheumatoid arthritis: some considerations based on a northern Italian population. J Rheumatol 1993;20:756-7.
8. Wagner U, Kaltenhauser S, Sauer H et al. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 1997;40:341-51.
9. Weyand CM, McCarthy TG, Goronzy JJ. Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis. J Clin Invest 1995;95:2120-6.
10. Nepom GT. Structural and genetic features of human leukocytic antigen class II elements associated with rheumatoid arthritis. Am J Med 1988;85:12-3.
11. Sansom DM, Bidwell JL, Maddison PJ, Campion G, Klouda PT, Bradley BA. HLA DQ alpha and DQ beta restriction fragment length polymorphisms associated with Felty's syndrome and DR4-positive rheumatoid arthritis. Hum Immunol 1987;19:269-78.
12. Stephens HA, Sakkas LI, Vaughan RW, Teitsson I, Welsh KI, Panayi GS. HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis. Immunogenetics 1989;30:119-22.
13. Clarkson R, Bate AS, Grennan DM et al. DQw7 and the C4B null allele in rheumatoid arthritis and Felty's syndrome. Ann Rheum Dis 1990;49:976-9.
14. McCusker CT, Reid B, Green D, Gladman DD, Buchanan WW, Singal DP. HLA-D region antigens in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:192-7.
15. Singal DP, Green D, Reid B, Gladman DD, Buchanan WW. HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis 1992;51:23-8.
16. Hillarby MC, Ollier WE, Davis M, Davidson J, Sanders PA, Grennan DM. Unusual DQA-DR haplotypes in rheumatoid vasculitis. Br J Rheumatol 1993;32:93-6.
17. Zanelli E, Krco CJ, Baisch JM, Cheng S, David CS. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc Natl Acad Sci USA 1996;93:1814-9.
18. van der Horst-Bruinsma IE, Visser H, Hazes JM, Breedveld FC et al. HLA-DQ-associated predisposition to and dominant HLA-DR-associated protection against rheumatoid arthritis. Hum Immunol 1999;60:152-8.
19. Zanelli E, Krco CJ, David CS. Critical residues on HLA-DRB1*0402 HV3 peptide for HLA-DQ8-restricted immunogenicity: implications for rheumatoid arthritis predisposition. J Immunol 1997;158:3545-51.
20. Seidl C, Korbitzer J, Badenhoop K et al. Protection against severe disease is conferred by DERAA-bearing HLA-DRB1 alleles among HLA-DQ3 and HLA-DQ5 positive rheumatoid arthritis patients. Hum Immunol 2001;62:523-9.
21. Vos K, van Der Horst-Bruinsma IE, Hazes JM et al. Evidence for a protective role of the human leukocyte antigen class II region in early rheumatoid arthritis. Rheumatology 2001;40:133-9.
22. Kaltenhauser S, Wagner U, Wassmuth R et al. Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity. J Rheumatol 2001;28:734-44.
23. Bignon JD, Fernandez-Vina MA, Cheneau ML et al. HLA-DNA class II typing by PCR-SSOP: 12th International Workshop experience. In: Charron D, ed. Genetic diversity of HLA, functional and medical implication. Proceedings of the Twelfth International Histocompatibility Workshop and Conference. Paris: EDK, 1997:21-5.
24. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976;103:226-35.
25. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955;19:251-3.
26. Haldane S. The estimated significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956;20:309-11.
27. Mantel N, Haenzsel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
28. Michelsen B, Wassmuth R, Ludvigsson J, Lernmark A, Nepom GT, Fisher L. HLA heterozygosity in insulin-dependent diabetes is most frequent at the DQ locus. Scand J Immunol 1990;31:405-13.
29. Rosner BA. Fundamentals of biostatistics. Boston: Duxbury Press, 1982.
30. Felson DT, Anderson JJ, Boers M et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
31. Mottonen T, Paimela L, Leirisalo-Repo M, Kautiainen H, Ilonen J, Hannonen P. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with 'sawtooth' strategy. Ann Rheum Dis 1998;57:533-9.
32. Fex E, Jonsson K, Johnson U, Eberhardt K. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort. Br J Rheumatol 1996;35:1106-15.
33. Emery P, Symmons D. What is early rheumatoid arthritis? Definition and diagnosis? In: Woolf AD, van Riel PLCM, eds. Bailliere's Clinical Rheumatology. London: Bailliere Tindall, 1997:13-26.
34. de Vries N, van Elderen C, Tijssen H, van Riel PL, van de Putte LB. No support for HLA-DQ encoded susceptibility in rheumatoid arthritis. Arthritis Rheum 1999;42:1621-7.
35. Mattey DL, Hassell AB, Plant MJ et al. The influence of HLA-DRB1 alleles encoding the DERAA amino acid motif on radiological outcome in rheumatoid arthritis. Rheumatology 1999;38:1221-7.
36. O'Dell JR, Nepom BS, Haire C et al. HLA-DRB1 typing in rheumatoid arthritis: predicting response to specific treatments. Ann Rheum Dis 1998;57:209-13.
37. Lipsky PE, van der Heijde DM, St Clair EW et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 2000;343:1594-602.